Infinimmune

Infinimmune discovers and develops next-generation antibody therapeutics with strong affinity, specificity, and long half-life.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2026
Infinimmune Hover Image